Global Morphine Sulfate Extended Release Tablets Market Growth 2026-2032
The global Morphine Sulfate Extended Release Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Morphine Sulfate Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Morphine Sulfate Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Morphine Sulfate Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Morphine Sulfate Extended Release Tablets players cover NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Morphine Sulfate Extended Release Tablets Industry Forecast? looks at past sales and reviews total world Morphine Sulfate Extended Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Sulfate Extended Release Tablets sales for 2026 through 2032. With Morphine Sulfate Extended Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Sulfate Extended Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Morphine Sulfate Extended Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Sulfate Extended Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Morphine Sulfate Extended Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Sulfate Extended Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Sulfate Extended Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Sulfate Extended Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Morphine Sulfate Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Morphine Sulfate Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Morphine Sulfate Extended Release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Morphine Sulfate Extended Release Tablets players cover NAPP PHARMACEUTICALS LIMITED, Purdue Pharma, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Viatris, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Morphine Sulfate Extended Release Tablets Industry Forecast? looks at past sales and reviews total world Morphine Sulfate Extended Release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Morphine Sulfate Extended Release Tablets sales for 2026 through 2032. With Morphine Sulfate Extended Release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Morphine Sulfate Extended Release Tablets industry.
This Insight Report provides a comprehensive analysis of the global Morphine Sulfate Extended Release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Morphine Sulfate Extended Release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Morphine Sulfate Extended Release Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Morphine Sulfate Extended Release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Morphine Sulfate Extended Release Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Morphine Sulfate Extended Release Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 10mg
- 30mg
- 60mg
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NAPP PHARMACEUTICALS LIMITED
- Purdue Pharma
- Mallinckrodt Pharmaceuticals
- Teva Pharmaceuticals
- Viatris
- Allergan
- Rhodes Pharmaceuticals
- West-Ward Pharmaceuticals
- What is the 10-year outlook for the global Morphine Sulfate Extended Release Tablets market?
- What factors are driving Morphine Sulfate Extended Release Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doMorphine Sulfate Extended Release Tablets market opportunities vary by end market size?
- How does Morphine Sulfate Extended Release Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Morphine Sulfate Extended Release Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Morphine Sulfate Extended Release Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Morphine Sulfate Extended Release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Morphine Sulfate Extended Release Tablets Segment by Type
2.2.1 10mg
2.2.2 30mg
2.2.3 60mg
2.2.4 Morphine Sulfate Extended Release Tablets Sales by Type
2.2.4.1 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Morphine Sulfate Extended Release Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Morphine Sulfate Extended Release Tablets Sale Price by Type (2021-2026)
2.3 Morphine Sulfate Extended Release Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Morphine Sulfate Extended Release Tablets Sales by Application
2.3.4.1 Global Morphine Sulfate Extended Release Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Morphine Sulfate Extended Release Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Morphine Sulfate Extended Release Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Morphine Sulfate Extended Release Tablets Breakdown Data by Company
3.1.1 Global Morphine Sulfate Extended Release Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Morphine Sulfate Extended Release Tablets Revenue by Company (2021-2026)
3.2.2 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Morphine Sulfate Extended Release Tablets Sale Price by Company
3.4 Key Manufacturers Morphine Sulfate Extended Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Sulfate Extended Release Tablets Product Location Distribution
3.4.2 Players Morphine Sulfate Extended Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MORPHINE SULFATE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Morphine Sulfate Extended Release Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Morphine Sulfate Extended Release Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Morphine Sulfate Extended Release Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Morphine Sulfate Extended Release Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Morphine Sulfate Extended Release Tablets Sales Growth
4.4 APAC Morphine Sulfate Extended Release Tablets Sales Growth
4.5 Europe Morphine Sulfate Extended Release Tablets Sales Growth
4.6 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Morphine Sulfate Extended Release Tablets Sales by Country
5.1.1 Americas Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026)
5.1.2 Americas Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026)
5.2 Americas Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
5.3 Americas Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Sulfate Extended Release Tablets Sales by Region
6.1.1 APAC Morphine Sulfate Extended Release Tablets Sales by Region (2021-2026)
6.1.2 APAC Morphine Sulfate Extended Release Tablets Revenue by Region (2021-2026)
6.2 APAC Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
6.3 APAC Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Morphine Sulfate Extended Release Tablets by Country
7.1.1 Europe Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026)
7.1.2 Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026)
7.2 Europe Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
7.3 Europe Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Morphine Sulfate Extended Release Tablets by Country
8.1.1 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Sulfate Extended Release Tablets
10.3 Manufacturing Process Analysis of Morphine Sulfate Extended Release Tablets
10.4 Industry Chain Structure of Morphine Sulfate Extended Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Sulfate Extended Release Tablets Distributors
11.3 Morphine Sulfate Extended Release Tablets Customer
12 WORLD FORECAST REVIEW FOR MORPHINE SULFATE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Morphine Sulfate Extended Release Tablets Market Size Forecast by Region
12.1.1 Global Morphine Sulfate Extended Release Tablets Forecast by Region (2027-2032)
12.1.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Morphine Sulfate Extended Release Tablets Forecast by Type (2027-2032)
12.7 Global Morphine Sulfate Extended Release Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 NAPP PHARMACEUTICALS LIMITED
13.1.1 NAPP PHARMACEUTICALS LIMITED Company Information
13.1.2 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.1.3 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 NAPP PHARMACEUTICALS LIMITED Main Business Overview
13.1.5 NAPP PHARMACEUTICALS LIMITED Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.2.3 Purdue Pharma Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.5.3 Viatris Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.6.3 Allergan Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Rhodes Pharmaceuticals
13.7.1 Rhodes Pharmaceuticals Company Information
13.7.2 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.7.3 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Rhodes Pharmaceuticals Main Business Overview
13.7.5 Rhodes Pharmaceuticals Latest Developments
13.8 West-Ward Pharmaceuticals
13.8.1 West-Ward Pharmaceuticals Company Information
13.8.2 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.8.3 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 West-Ward Pharmaceuticals Main Business Overview
13.8.5 West-Ward Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Morphine Sulfate Extended Release Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Morphine Sulfate Extended Release Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Morphine Sulfate Extended Release Tablets by Country/Region, 2021, 2025 & 2032
2.2 Morphine Sulfate Extended Release Tablets Segment by Type
2.2.1 10mg
2.2.2 30mg
2.2.3 60mg
2.2.4 Morphine Sulfate Extended Release Tablets Sales by Type
2.2.4.1 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Morphine Sulfate Extended Release Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Morphine Sulfate Extended Release Tablets Sale Price by Type (2021-2026)
2.3 Morphine Sulfate Extended Release Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Morphine Sulfate Extended Release Tablets Sales by Application
2.3.4.1 Global Morphine Sulfate Extended Release Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Morphine Sulfate Extended Release Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Morphine Sulfate Extended Release Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Morphine Sulfate Extended Release Tablets Breakdown Data by Company
3.1.1 Global Morphine Sulfate Extended Release Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Morphine Sulfate Extended Release Tablets Sales Market Share by Company (2021-2026)
3.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Morphine Sulfate Extended Release Tablets Revenue by Company (2021-2026)
3.2.2 Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Morphine Sulfate Extended Release Tablets Sale Price by Company
3.4 Key Manufacturers Morphine Sulfate Extended Release Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Morphine Sulfate Extended Release Tablets Product Location Distribution
3.4.2 Players Morphine Sulfate Extended Release Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MORPHINE SULFATE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Morphine Sulfate Extended Release Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Morphine Sulfate Extended Release Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Morphine Sulfate Extended Release Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Morphine Sulfate Extended Release Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Morphine Sulfate Extended Release Tablets Sales Growth
4.4 APAC Morphine Sulfate Extended Release Tablets Sales Growth
4.5 Europe Morphine Sulfate Extended Release Tablets Sales Growth
4.6 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Growth
5 AMERICAS
5.1 Americas Morphine Sulfate Extended Release Tablets Sales by Country
5.1.1 Americas Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026)
5.1.2 Americas Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026)
5.2 Americas Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
5.3 Americas Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Morphine Sulfate Extended Release Tablets Sales by Region
6.1.1 APAC Morphine Sulfate Extended Release Tablets Sales by Region (2021-2026)
6.1.2 APAC Morphine Sulfate Extended Release Tablets Revenue by Region (2021-2026)
6.2 APAC Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
6.3 APAC Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Morphine Sulfate Extended Release Tablets by Country
7.1.1 Europe Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026)
7.1.2 Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026)
7.2 Europe Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
7.3 Europe Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Morphine Sulfate Extended Release Tablets by Country
8.1.1 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Morphine Sulfate Extended Release Tablets
10.3 Manufacturing Process Analysis of Morphine Sulfate Extended Release Tablets
10.4 Industry Chain Structure of Morphine Sulfate Extended Release Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Morphine Sulfate Extended Release Tablets Distributors
11.3 Morphine Sulfate Extended Release Tablets Customer
12 WORLD FORECAST REVIEW FOR MORPHINE SULFATE EXTENDED RELEASE TABLETS BY GEOGRAPHIC REGION
12.1 Global Morphine Sulfate Extended Release Tablets Market Size Forecast by Region
12.1.1 Global Morphine Sulfate Extended Release Tablets Forecast by Region (2027-2032)
12.1.2 Global Morphine Sulfate Extended Release Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Morphine Sulfate Extended Release Tablets Forecast by Type (2027-2032)
12.7 Global Morphine Sulfate Extended Release Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 NAPP PHARMACEUTICALS LIMITED
13.1.1 NAPP PHARMACEUTICALS LIMITED Company Information
13.1.2 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.1.3 NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 NAPP PHARMACEUTICALS LIMITED Main Business Overview
13.1.5 NAPP PHARMACEUTICALS LIMITED Latest Developments
13.2 Purdue Pharma
13.2.1 Purdue Pharma Company Information
13.2.2 Purdue Pharma Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.2.3 Purdue Pharma Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Purdue Pharma Main Business Overview
13.2.5 Purdue Pharma Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.5.3 Viatris Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.6.3 Allergan Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 Rhodes Pharmaceuticals
13.7.1 Rhodes Pharmaceuticals Company Information
13.7.2 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.7.3 Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Rhodes Pharmaceuticals Main Business Overview
13.7.5 Rhodes Pharmaceuticals Latest Developments
13.8 West-Ward Pharmaceuticals
13.8.1 West-Ward Pharmaceuticals Company Information
13.8.2 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
13.8.3 West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 West-Ward Pharmaceuticals Main Business Overview
13.8.5 West-Ward Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Morphine Sulfate Extended Release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Morphine Sulfate Extended Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg
Table 4. Major Players of 30mg
Table 5. Major Players of 60mg
Table 6. Global Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 7. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Morphine Sulfate Extended Release Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Morphine Sulfate Extended Release Tablets Sale Price by Type (2021-2026) & (US$/Ton)
Table 11. Global Morphine Sulfate Extended Release Tablets Sale by Application (2021-2026) & (Tons)
Table 12. Global Morphine Sulfate Extended Release Tablets Sale Market Share by Application (2021-2026)
Table 13. Global Morphine Sulfate Extended Release Tablets Revenue by Application (2021-2026) & ($ million)
Table 14. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2021-2026)
Table 15. Global Morphine Sulfate Extended Release Tablets Sale Price by Application (2021-2026) & (US$/Ton)
Table 16. Global Morphine Sulfate Extended Release Tablets Sales by Company (2021-2026) & (Tons)
Table 17. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Company (2021-2026)
Table 18. Global Morphine Sulfate Extended Release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Company (2021-2026)
Table 20. Global Morphine Sulfate Extended Release Tablets Sale Price by Company (2021-2026) & (US$/Ton)
Table 21. Key Manufacturers Morphine Sulfate Extended Release Tablets Producing Area Distribution and Sales Area
Table 22. Players Morphine Sulfate Extended Release Tablets Products Offered
Table 23. Morphine Sulfate Extended Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Morphine Sulfate Extended Release Tablets Sales by Geographic Region (2021-2026) & (Tons)
Table 27. Global Morphine Sulfate Extended Release Tablets Sales Market Share Geographic Region (2021-2026)
Table 28. Global Morphine Sulfate Extended Release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Morphine Sulfate Extended Release Tablets Sales by Country/Region (2021-2026) & (Tons)
Table 31. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Country/Region (2021-2026)
Table 32. Global Morphine Sulfate Extended Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026) & (Tons)
Table 35. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021-2026)
Table 36. Americas Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 38. Americas Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 39. APAC Morphine Sulfate Extended Release Tablets Sales by Region (2021-2026) & (Tons)
Table 40. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2021-2026)
Table 41. APAC Morphine Sulfate Extended Release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 43. APAC Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 44. Europe Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026) & (Tons)
Table 45. Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 47. Europe Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 48. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026) & (Tons)
Table 49. Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 51. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Morphine Sulfate Extended Release Tablets
Table 53. Key Market Challenges & Risks of Morphine Sulfate Extended Release Tablets
Table 54. Key Industry Trends of Morphine Sulfate Extended Release Tablets
Table 55. Morphine Sulfate Extended Release Tablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Morphine Sulfate Extended Release Tablets Distributors List
Table 58. Morphine Sulfate Extended Release Tablets Customer List
Table 59. Global Morphine Sulfate Extended Release Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 60. Global Morphine Sulfate Extended Release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Morphine Sulfate Extended Release Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 62. Americas Morphine Sulfate Extended Release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Morphine Sulfate Extended Release Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 64. APAC Morphine Sulfate Extended Release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Morphine Sulfate Extended Release Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 66. Europe Morphine Sulfate Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Morphine Sulfate Extended Release Tablets Sales Forecast by Type (2027-2032) & (Tons)
Table 70. Global Morphine Sulfate Extended Release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Morphine Sulfate Extended Release Tablets Sales Forecast by Application (2027-2032) & (Tons)
Table 72. Global Morphine Sulfate Extended Release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. NAPP PHARMACEUTICALS LIMITED Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 74. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 75. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 76. NAPP PHARMACEUTICALS LIMITED Main Business
Table 77. NAPP PHARMACEUTICALS LIMITED Latest Developments
Table 78. Purdue Pharma Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Purdue Pharma Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 80. Purdue Pharma Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 81. Purdue Pharma Main Business
Table 82. Purdue Pharma Latest Developments
Table 83. Mallinckrodt Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 85. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 86. Mallinckrodt Pharmaceuticals Main Business
Table 87. Mallinckrodt Pharmaceuticals Latest Developments
Table 88. Teva Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 90. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. Teva Pharmaceuticals Main Business
Table 92. Teva Pharmaceuticals Latest Developments
Table 93. Viatris Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 95. Viatris Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. Allergan Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Allergan Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 100. Allergan Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Allergan Main Business
Table 102. Allergan Latest Developments
Table 103. Rhodes Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 105. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Rhodes Pharmaceuticals Main Business
Table 107. Rhodes Pharmaceuticals Latest Developments
Table 108. West-Ward Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 110. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. West-Ward Pharmaceuticals Main Business
Table 112. West-Ward Pharmaceuticals Latest Developments
Table 1. Morphine Sulfate Extended Release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Morphine Sulfate Extended Release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 10mg
Table 4. Major Players of 30mg
Table 5. Major Players of 60mg
Table 6. Global Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 7. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Morphine Sulfate Extended Release Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Morphine Sulfate Extended Release Tablets Sale Price by Type (2021-2026) & (US$/Ton)
Table 11. Global Morphine Sulfate Extended Release Tablets Sale by Application (2021-2026) & (Tons)
Table 12. Global Morphine Sulfate Extended Release Tablets Sale Market Share by Application (2021-2026)
Table 13. Global Morphine Sulfate Extended Release Tablets Revenue by Application (2021-2026) & ($ million)
Table 14. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application (2021-2026)
Table 15. Global Morphine Sulfate Extended Release Tablets Sale Price by Application (2021-2026) & (US$/Ton)
Table 16. Global Morphine Sulfate Extended Release Tablets Sales by Company (2021-2026) & (Tons)
Table 17. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Company (2021-2026)
Table 18. Global Morphine Sulfate Extended Release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Company (2021-2026)
Table 20. Global Morphine Sulfate Extended Release Tablets Sale Price by Company (2021-2026) & (US$/Ton)
Table 21. Key Manufacturers Morphine Sulfate Extended Release Tablets Producing Area Distribution and Sales Area
Table 22. Players Morphine Sulfate Extended Release Tablets Products Offered
Table 23. Morphine Sulfate Extended Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Morphine Sulfate Extended Release Tablets Sales by Geographic Region (2021-2026) & (Tons)
Table 27. Global Morphine Sulfate Extended Release Tablets Sales Market Share Geographic Region (2021-2026)
Table 28. Global Morphine Sulfate Extended Release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Morphine Sulfate Extended Release Tablets Sales by Country/Region (2021-2026) & (Tons)
Table 31. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Country/Region (2021-2026)
Table 32. Global Morphine Sulfate Extended Release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026) & (Tons)
Table 35. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021-2026)
Table 36. Americas Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 38. Americas Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 39. APAC Morphine Sulfate Extended Release Tablets Sales by Region (2021-2026) & (Tons)
Table 40. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Region (2021-2026)
Table 41. APAC Morphine Sulfate Extended Release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 43. APAC Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 44. Europe Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026) & (Tons)
Table 45. Europe Morphine Sulfate Extended Release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 47. Europe Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 48. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Country (2021-2026) & (Tons)
Table 49. Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Type (2021-2026) & (Tons)
Table 51. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales by Application (2021-2026) & (Tons)
Table 52. Key Market Drivers & Growth Opportunities of Morphine Sulfate Extended Release Tablets
Table 53. Key Market Challenges & Risks of Morphine Sulfate Extended Release Tablets
Table 54. Key Industry Trends of Morphine Sulfate Extended Release Tablets
Table 55. Morphine Sulfate Extended Release Tablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Morphine Sulfate Extended Release Tablets Distributors List
Table 58. Morphine Sulfate Extended Release Tablets Customer List
Table 59. Global Morphine Sulfate Extended Release Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 60. Global Morphine Sulfate Extended Release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Morphine Sulfate Extended Release Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 62. Americas Morphine Sulfate Extended Release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Morphine Sulfate Extended Release Tablets Sales Forecast by Region (2027-2032) & (Tons)
Table 64. APAC Morphine Sulfate Extended Release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Morphine Sulfate Extended Release Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 66. Europe Morphine Sulfate Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Forecast by Country (2027-2032) & (Tons)
Table 68. Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Morphine Sulfate Extended Release Tablets Sales Forecast by Type (2027-2032) & (Tons)
Table 70. Global Morphine Sulfate Extended Release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Morphine Sulfate Extended Release Tablets Sales Forecast by Application (2027-2032) & (Tons)
Table 72. Global Morphine Sulfate Extended Release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. NAPP PHARMACEUTICALS LIMITED Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 74. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 75. NAPP PHARMACEUTICALS LIMITED Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 76. NAPP PHARMACEUTICALS LIMITED Main Business
Table 77. NAPP PHARMACEUTICALS LIMITED Latest Developments
Table 78. Purdue Pharma Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Purdue Pharma Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 80. Purdue Pharma Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 81. Purdue Pharma Main Business
Table 82. Purdue Pharma Latest Developments
Table 83. Mallinckrodt Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 85. Mallinckrodt Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 86. Mallinckrodt Pharmaceuticals Main Business
Table 87. Mallinckrodt Pharmaceuticals Latest Developments
Table 88. Teva Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 90. Teva Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 91. Teva Pharmaceuticals Main Business
Table 92. Teva Pharmaceuticals Latest Developments
Table 93. Viatris Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Viatris Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 95. Viatris Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 96. Viatris Main Business
Table 97. Viatris Latest Developments
Table 98. Allergan Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Allergan Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 100. Allergan Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 101. Allergan Main Business
Table 102. Allergan Latest Developments
Table 103. Rhodes Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 105. Rhodes Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 106. Rhodes Pharmaceuticals Main Business
Table 107. Rhodes Pharmaceuticals Latest Developments
Table 108. West-Ward Pharmaceuticals Basic Information, Morphine Sulfate Extended Release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Product Portfolios and Specifications
Table 110. West-Ward Pharmaceuticals Morphine Sulfate Extended Release Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 111. West-Ward Pharmaceuticals Main Business
Table 112. West-Ward Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Morphine Sulfate Extended Release Tablets
Figure 2. Morphine Sulfate Extended Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Sulfate Extended Release Tablets Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Morphine Sulfate Extended Release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Morphine Sulfate Extended Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Morphine Sulfate Extended Release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Morphine Sulfate Extended Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg
Figure 12. Product Picture of 30mg
Figure 13. Product Picture of 60mg
Figure 14. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type in 2026
Figure 15. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Morphine Sulfate Extended Release Tablets Consumed in Hospital
Figure 17. Global Morphine Sulfate Extended Release Tablets Market: Hospital (2021-2026) & (Tons)
Figure 18. Morphine Sulfate Extended Release Tablets Consumed in Clinic
Figure 19. Global Morphine Sulfate Extended Release Tablets Market: Clinic (2021-2026) & (Tons)
Figure 20. Morphine Sulfate Extended Release Tablets Consumed in Others
Figure 21. Global Morphine Sulfate Extended Release Tablets Market: Others (2021-2026) & (Tons)
Figure 22. Global Morphine Sulfate Extended Release Tablets Sale Market Share by Application (2025)
Figure 23. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application in 2026
Figure 24. Morphine Sulfate Extended Release Tablets Sales by Company in 2026 (Tons)
Figure 25. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Company in 2026
Figure 26. Morphine Sulfate Extended Release Tablets Revenue by Company in 2026 ($ millions)
Figure 27. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Company in 2026
Figure 28. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 31. Americas Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 32. APAC Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 33. APAC Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 34. Europe Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 35. Europe Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 37. Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 38. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Country in 2026
Figure 39. Americas Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 40. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 41. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 42. United States Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Region in 2026
Figure 47. APAC Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2021-2026)
Figure 48. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 49. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 50. China Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. India Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Country in 2026
Figure 58. Europe Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 59. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 60. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 61. Germany Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. France Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 69. Egypt Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Morphine Sulfate Extended Release Tablets in 2026
Figure 75. Manufacturing Process Analysis of Morphine Sulfate Extended Release Tablets
Figure 76. Industry Chain Structure of Morphine Sulfate Extended Release Tablets
Figure 77. Channels of Distribution
Figure 78. Global Morphine Sulfate Extended Release Tablets Sales Market Forecast by Region (2027-2032)
Figure 79. Global Morphine Sulfate Extended Release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Morphine Sulfate Extended Release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Morphine Sulfate Extended Release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Morphine Sulfate Extended Release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Morphine Sulfate Extended Release Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Morphine Sulfate Extended Release Tablets
Figure 2. Morphine Sulfate Extended Release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Morphine Sulfate Extended Release Tablets Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Morphine Sulfate Extended Release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Morphine Sulfate Extended Release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Morphine Sulfate Extended Release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Morphine Sulfate Extended Release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 10mg
Figure 12. Product Picture of 30mg
Figure 13. Product Picture of 60mg
Figure 14. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Type in 2026
Figure 15. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Morphine Sulfate Extended Release Tablets Consumed in Hospital
Figure 17. Global Morphine Sulfate Extended Release Tablets Market: Hospital (2021-2026) & (Tons)
Figure 18. Morphine Sulfate Extended Release Tablets Consumed in Clinic
Figure 19. Global Morphine Sulfate Extended Release Tablets Market: Clinic (2021-2026) & (Tons)
Figure 20. Morphine Sulfate Extended Release Tablets Consumed in Others
Figure 21. Global Morphine Sulfate Extended Release Tablets Market: Others (2021-2026) & (Tons)
Figure 22. Global Morphine Sulfate Extended Release Tablets Sale Market Share by Application (2025)
Figure 23. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Application in 2026
Figure 24. Morphine Sulfate Extended Release Tablets Sales by Company in 2026 (Tons)
Figure 25. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Company in 2026
Figure 26. Morphine Sulfate Extended Release Tablets Revenue by Company in 2026 ($ millions)
Figure 27. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Company in 2026
Figure 28. Global Morphine Sulfate Extended Release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Morphine Sulfate Extended Release Tablets Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 31. Americas Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 32. APAC Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 33. APAC Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 34. Europe Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 35. Europe Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales 2021-2026 (Tons)
Figure 37. Middle East & Africa Morphine Sulfate Extended Release Tablets Revenue 2021-2026 ($ millions)
Figure 38. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Country in 2026
Figure 39. Americas Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 40. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 41. Americas Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 42. United States Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Region in 2026
Figure 47. APAC Morphine Sulfate Extended Release Tablets Revenue Market Share by Region (2021-2026)
Figure 48. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 49. APAC Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 50. China Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. India Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Country in 2026
Figure 58. Europe Morphine Sulfate Extended Release Tablets Revenue Market Share by Country (2021-2026)
Figure 59. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 60. Europe Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 61. Germany Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. France Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Morphine Sulfate Extended Release Tablets Sales Market Share by Application (2021-2026)
Figure 69. Egypt Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Morphine Sulfate Extended Release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Morphine Sulfate Extended Release Tablets in 2026
Figure 75. Manufacturing Process Analysis of Morphine Sulfate Extended Release Tablets
Figure 76. Industry Chain Structure of Morphine Sulfate Extended Release Tablets
Figure 77. Channels of Distribution
Figure 78. Global Morphine Sulfate Extended Release Tablets Sales Market Forecast by Region (2027-2032)
Figure 79. Global Morphine Sulfate Extended Release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Morphine Sulfate Extended Release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Morphine Sulfate Extended Release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Morphine Sulfate Extended Release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Morphine Sulfate Extended Release Tablets Revenue Market Share Forecast by Application (2027-2032)
